| Matrix metalloproteases in pancreatic ductal adenocarcinoma: key drivers of disease progression? EJ Slapak, JW Duitman, C Tekin, MF Bijlsma, CA Spek Biology 9 (4), 80, 2020 | 59 | 2020 |
| Macrophage-secreted MMP9 induces mesenchymal transition in pancreatic cancer cells via PAR1 activation C Tekin, HL Aberson, C Waasdorp, GKJ Hooijer, OJ de Boer, F Dijk, ... Cellular Oncology 43, 1161-1174, 2020 | 50 | 2020 |
| High‐grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF‐1 A Steins, MG van Mackelenbergh, AP van der Zalm, R Klaassen, ... EMBO reports 21 (5), e48780, 2020 | 33 | 2020 |
| PAR1 signaling on tumor cells limits tumor growth by maintaining a mesenchymal phenotype in pancreatic cancer C Tekin, K Shi, A Spek, MF Bijlsma Oncotarget, 2018 | 28 | 2018 |
| Early macrophage infiltrates impair pancreatic cancer cell growth by TNF-α secretion C Tekin, HL Aberson, MF Bijlsma, CA Spek BMC cancer 20, 1-9, 2020 | 21 | 2020 |
| Protease‐activated receptor‐1 impedes prostate and intestinal tumor progression in mice: comment CA Spek, C Tekin, MF Bijlsma Journal of Thrombosis and Haemostasis 17 (1), 235-238, 2019 | 3 | 2019 |
| Protease‐activated receptor 1 drives and maintains ductal cell fates in the premalignant pancreas and ductal adenocarcinoma C Tekin, BP Scicluna, SC Lodestijn, K Shi, MF Bijlsma, CA Spek Molecular Oncology 15 (11), 3091-3108, 2021 | 2 | 2021 |
| The role of protease-activated receptor-1 in pancreatic cancer progression C Tekin | | 2021 |
| Early macrophage infiltrates impair pancreatic cancer cell growth by TNF-a secretion C Tekin, HL Aberson, AUM Centra, MF Bijlsma, CA Spek | | |
Maarten Fokke BijlsmaAmsterdam UMC, location AMCVerified email at amc.uva.nl
